{
    "clinical_study": {
        "@rank": "139770", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor\n      cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of combining doxorubicin and ifosfamide\n      in treating patients who have metastatic kidney cancer."
        }, 
        "brief_title": "Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer", 
        "condition": "Kidney Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Renal Cell", 
                "Kidney Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the efficacy in terms of objective response after treatment with\n      ifosfamide and doxorubicin in patients with metastatic sarcomatoid renal cell cancer. II.\n      Determine the toxicity of this regimen in these patients. III. Determine the effect of this\n      regimen on the survival of these patients.\n\n      OUTLINE: This is a multicenter study. Patients receive doxorubicin IV on day 1 and\n      ifosfamide IV over 2 hours on days 1 and 2. Treatment is repeated every 3 weeks for up to 8\n      courses in the absence of disease progression or unacceptable toxicity.\n\n      PROJECTED ACCRUAL: A total of 20-40 patients will be accrued for this study within 3 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven metastatic, sarcomatoid renal cell\n        carcinoma Measurable disease At least 15 mm for pulmonary sites At least 20 mm for other\n        sites No uncontrolled CNS metastases\n\n        PATIENT CHARACTERISTICS: Age: 18 and over Performance status: WHO 0-2 Life expectancy:\n        Greater than 3 months Hematopoietic: Neutrophil count greater than 1500/mm3 Platelet count\n        greater than 100,000/mm3 Hemoglobin greater than 9 g/dL Hepatic: Bilirubin less than 1.5\n        times normal Transaminases less than 2 times normal (less than 4 times normal if due to\n        liver metastases) Renal: Creatinine less than 1.6 mg/dL Creatinine clearance greater than\n        60 mL/min Other: No contraindication to anthracycline treatment No unstable major organ\n        defect No prior malignancy except basal cell skin cancer or carcinoma in situ of the\n        uterus Not pregnant or nursing Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No prior immunotherapy Chemotherapy: No prior\n        chemotherapy Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not\n        specified"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003683", 
            "org_study_id": "CDR0000066785", 
            "secondary_id": [
                "FRE-FNCLCC-REINSARDI", 
                "EU-98057"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "ifosfamide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxorubicin", 
                "Isophosphamide mustard", 
                "Ifosfamide"
            ]
        }, 
        "keyword": "stage IV renal cell cancer", 
        "lastchanged_date": "July 23, 2008", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-FNCLCC-REINSARDI"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Avignon", 
                        "country": "France", 
                        "zip": "84082"
                    }, 
                    "name": "Institut Sainte Catherine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13273"
                    }, 
                    "name": "Institut J. Paoli and I. Calmettes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30006"
                    }, 
                    "name": "C.H.U. - Hopital Gaston Doumergue"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75248"
                    }, 
                    "name": "Institut Curie - Section Medicale"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75181"
                    }, 
                    "name": "Hotel Dieu de Paris"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51056"
                    }, 
                    "name": "Institut Jean Godinot"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35064"
                    }, 
                    "name": "Centre Eugene Marquis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Cloud", 
                        "country": "France", 
                        "zip": "92211"
                    }, 
                    "name": "Centre Rene Huguenin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Nazaire", 
                        "country": "France", 
                        "zip": "44600"
                    }, 
                    "name": "Centre Hospitalier General de Saint Nazaire"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "official_title": "Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study", 
        "overall_official": {
            "affiliation": "Centre Val d'Aurelle - Paul Lamarque", 
            "last_name": "Stephane Culine, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003683"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNICANCER", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2002"
    }, 
    "geocoordinates": {
        "C.H.U. - Hopital Gaston Doumergue": "43.837 4.36", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Eugene Marquis": "48.113 -1.676", 
        "Centre Hospitalier General de Saint Nazaire": "47.273 -2.214", 
        "Centre Leon Berard": "45.764 4.836", 
        "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle": "43.611 3.877", 
        "Centre Rene Huguenin": "48.848 2.208", 
        "Hotel Dieu de Paris": "48.857 2.352", 
        "Institut Curie - Section Medicale": "48.857 2.352", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Institut J. Paoli and I. Calmettes": "43.296 5.37", 
        "Institut Jean Godinot": "49.258 4.032", 
        "Institut Sainte Catherine": "43.949 4.806"
    }
}